designer drug
Sign in to saveAlso known as new psychoactive substances, designer drugs, synthetic drugs, novel psychoactive substance, NPS
class of recreational drugs
Research
4,701 papers- Designer Drugs 2.0.Clinical pharmacology and therapeutics · 2017
- Research Status of New Designer Drug Methcathinone in Forensic Toxicology.Fa yi xue za zhi · 2018
- The New Designer Drug Wave: A Clinical, Toxicological, and Legal Analysis.Journal of psychoactive drugs · 2015
- Chemogenetics revealed: DREADD occupancy and activation via converted clozapine.Science (New York, N.Y.) · 2017
- Designer antibiotics.Nature reviews. Microbiology · 2024
via PubMed
Wikidata facts
- Subclass of
- drug
Show 2 more facts
- topic's main category
- Category:Designer drugs
- Commons category
- Designer drugs
via Wikidata · CC0
~20 min read
Encyclopedic overview
JWH-018, a popular cannabinoid A designer drug is a structural or functional analog of a controlled substance that has been designed to mimic the pharmacological effects of the original drug, while avoiding classification as illegal and/or detection in standard drug tests. Designer drugs include psychoactive substances that have been designated by the European Union, Australia, and New Zealand, as new psychoactive substances (NPS) as well as analogs of performance-enhancing drugs such as designer steroids.
Some designer drugs were originally synthesized by academic or industrial researchers and later emerged on the grey market for recreational use. Other designer drugs were prepared for the first time in clandestine laboratories. Many designer drugs have a short history of human use and have not been thoroughly evaluated in animal or human trials, leading to the possibility of unexpected effects and toxicities.
Excerpted from Wikipedia’s “designer drug” article, available under the CC BY-SA 4.0 licence.